JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology - Reportify

JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology

Businesswire·2025-10-08 00:30

公司技术平台 - JCR制药公司展示了其专有JUST-AAV平台的非临床数据 [1] - 数据显示该平台能够实现AAV基因疗法的高效递送 [1]